CN1213062C - 序列号13的生物活性肽 - Google Patents
序列号13的生物活性肽 Download PDFInfo
- Publication number
- CN1213062C CN1213062C CNB021410402A CN02141040A CN1213062C CN 1213062 C CN1213062 C CN 1213062C CN B021410402 A CNB021410402 A CN B021410402A CN 02141040 A CN02141040 A CN 02141040A CN 1213062 C CN1213062 C CN 1213062C
- Authority
- CN
- China
- Prior art keywords
- peptide
- group
- physiological saline
- compare
- significant difference
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
SEQ ID NO: | 肽名称 | 肽序列 |
1 | CMS001 | Pro Thr Thr Lys Thr Tyr Phe Pro His Phe |
2 | CMS002 | Val Val Tyr Pro Trp Thr Gln Arg Phe |
3 | CMS008 | Lys Ala Val Gly His Leu Asp Asp Leu Pro Gly Ala Leu |
4 | CMS010 | Val Ala Pro Glu Glu His Pro Thr Leu Leu Thr Glu Ala ProLeu Asn Pro Lys |
5 | CMS012 | Leu Gly Met Glu Ala Cys Gly Ile His Glu Thr Thr Tyr |
6 | CMS013 | Leu Arg Val Ala Pro Glu Glu His Pro Val Leu |
7 | CMS014 | Ala Ala His His Pro Asp Asp Phe Asn Pro Ser Val |
8 | CMS015 | Pro Ser Ile Val Gly Arg Pro Arg His Gln Gly Val Met |
9 | CMS016 | Ile Gly Met Glu Ser Ala Gly Ile His Glu Thr Thr Tyr |
10 | CMS018 | Val Gly Met Gly Glu Lys Asp Ser Tyr |
11 | CMS019 | Val Gly Met Gly Gln Lys Asp Ser Tyr |
12 | CMS020 | Val Gly Met Gly Gln Lys Asp Ser Tyr Val |
13 | CMS021 | Met Ala Thr Ala Ala Ser Ser Ser Ser Leu |
14 | CMS022 | Tyr Ser Phe |
15 | CMS023 | Ala Ala Phe |
16 | CMS024 | Tyr Ser Leu |
17 | CMS026 | Thr Thr Tyr Asn Ser Ile Met |
18 | CMS027 | Phe Glu Glu Asn Met |
19 | CMS028 | Phe Glu Pro Ser Phe |
20 | CMS029 | Phe Asn Glu Glu |
21 | CMS030 | Phe Glu Glu Met |
22 | CMS032 | Phe Glu Glu Glu |
23 | CMS033 | Phe Glu Ser Phe |
24 | CMS034 | Pro Glu Asn Phe |
25 | CMS035 | Phe Val Asn Asp |
26 | CMS036 | Phe Gln Pro Ser Phe |
27 | CMS003 | Phe Asn Phe Val Pro Pro |
28 | CMS007 | Ala Gly Asp Asp Ala Pro Arg Ala Val Phe |
29 | CMS009 | Leu Arg Val Ala Pro Glu Glu His Pro Thr Leu |
30 | CMS011 | Arg Val Ala Pro Glu Glu His Pro Thr Leu |
阳性对照组(g) | CMS015治疗组(g) | |||
雄性n=5 | 雌性n=5 | 雄性n=5 | 雌性n=5 | |
治疗前 | 145.6±13.6 | 133.6±46 | 145.6±8.5 | 129.2±3.3 |
治疗后第1周 | 194.4±14.5 | 164.4±8.7 | 183.8±10.6 | 157.8±8.3 |
治疗后第2周 | 239.6±13.4 | 188.0±6.4 | 220.6±12.2* | 176.0±11.2* |
治疗后第3周 | 265.0±11.8 | 208.8±8.2 | 239.0±16.0* | 196.0±10.5* |
治疗后第4周 | 287.4±17.7 | 227.2±8.2 | 258.2±18.1* | 212.0±13.5* |
治疗后第5周 | 299.4±21.2 | 236.6±10.9 | 268.8±17.7* | 221.4±13.2* |
治疗后第6周 | 333.4±27.1 | 249.4±16.3 | 299.4±21.2* | 235.6±16.3 |
治疗后第7周 | 349.2±28.9 | 261.2±13.4 | 310.4±25.9* | 242.2±18.8* |
治疗后第8周 | 374.4±37.2 | 255.6±11.5 | 337.4±30.6 | 252.8±22.5 |
Claims (9)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90449201A | 2001-07-13 | 2001-07-13 | |
US09/904,492 | 2001-07-13 | ||
US17868402A | 2002-06-20 | 2002-06-20 | |
US10/178,684 | 2002-06-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1398890A CN1398890A (zh) | 2003-02-26 |
CN1213062C true CN1213062C (zh) | 2005-08-03 |
Family
ID=26874547
Family Applications (30)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021410402A Expired - Fee Related CN1213062C (zh) | 2001-07-13 | 2002-07-11 | 序列号13的生物活性肽 |
CN021409862A Expired - Fee Related CN1216070C (zh) | 2001-07-13 | 2002-07-11 | 序列号20的生物活性肽 |
CNB021409870A Expired - Fee Related CN1210299C (zh) | 2001-07-13 | 2002-07-11 | 序列号19的生物活性肽 |
CNB021409714A Expired - Fee Related CN1210296C (zh) | 2001-07-13 | 2002-07-11 | 序列号30的生物活性肽 |
CNB021410372A Expired - Fee Related CN1210301C (zh) | 2001-07-13 | 2002-07-11 | 序列号18的生物活性肽 |
CNB021410410A Expired - Fee Related CN1213063C (zh) | 2001-07-13 | 2002-07-11 | 序列号12的生物活性肽 |
CN021409811A Expired - Fee Related CN1216072C (zh) | 2001-07-13 | 2002-07-11 | 序列号5的生物活性肽 |
CN02140982XA Expired - Fee Related CN1216073C (zh) | 2001-07-13 | 2002-07-11 | 序列号4的生物活性肽 |
CN021410437A Expired - Fee Related CN1216071C (zh) | 2001-07-13 | 2002-07-11 | 序列号27的生物活性肽 |
CNB021409846A Expired - Fee Related CN1210304C (zh) | 2001-07-13 | 2002-07-11 | 序列号3的生物活性肽 |
CNB021409838A Expired - Fee Related CN100412087C (zh) | 2001-07-13 | 2002-07-11 | 序列号2的生物活性肽 |
CN021409781A Expired - Fee Related CN1216069C (zh) | 2001-07-13 | 2002-07-11 | 序列号25的生物活性肽 |
CN021410399A Expired - Fee Related CN1216068C (zh) | 2001-07-13 | 2002-07-11 | 序列号14的生物活性肽 |
CNB021409854A Expired - Fee Related CN1210298C (zh) | 2001-07-13 | 2002-07-11 | 序列号1的生物活性肽 |
CNB02140979XA Expired - Fee Related CN1213060C (zh) | 2001-07-13 | 2002-07-11 | 序列号10的生物活性肽 |
CNB021409722A Expired - Fee Related CN1213065C (zh) | 2001-07-13 | 2002-07-11 | 序列号7的生物活性肽 |
CNB021409692A Expired - Fee Related CN1210293C (zh) | 2001-07-13 | 2002-07-11 | 序列号23的生物活性肽 |
CNB021409773A Expired - Fee Related CN1213067C (zh) | 2001-07-13 | 2002-07-11 | 序列号9的生物活性肽 |
CNB021410445A Expired - Fee Related CN1223603C (zh) | 2001-07-13 | 2002-07-11 | 序列号26的生物活性肽 |
CNB021410380A Expired - Fee Related CN1215081C (zh) | 2001-07-13 | 2002-07-11 | 序列号16的生物活性肽 |
CNB021410364A Expired - Fee Related CN1210300C (zh) | 2001-07-13 | 2002-07-11 | 序列号29的生物活性肽 |
CNB021409706A Expired - Fee Related CN1210294C (zh) | 2001-07-13 | 2002-07-11 | 序列号21的生物活性肽 |
CNB021410429A Expired - Fee Related CN1213064C (zh) | 2001-07-13 | 2002-07-11 | 序列号28的生物活性肽 |
CN021409757A Expired - Fee Related CN1216067C (zh) | 2001-07-13 | 2002-07-11 | 序列号15的生物活性肽 |
CNB021409749A Expired - Fee Related CN1210297C (zh) | 2001-07-13 | 2002-07-11 | 序列号17的生物活性肽 |
CNB021409684A Expired - Fee Related CN1210292C (zh) | 2001-07-13 | 2002-07-11 | 序列号22的生物活性肽 |
CNB021410356A Expired - Fee Related CN1223602C (zh) | 2001-07-13 | 2002-07-11 | 序列号11的生物活性肽 |
CNB021409803A Expired - Fee Related CN1213061C (zh) | 2001-07-13 | 2002-07-11 | 序列号6的生物活性肽 |
CNB021409730A Expired - Fee Related CN1210295C (zh) | 2001-07-13 | 2002-07-11 | 序列号24的生物活性肽 |
CNB021409765A Expired - Fee Related CN1213066C (zh) | 2001-07-13 | 2002-07-11 | 序列号8的生物活性肽 |
Family Applications After (29)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN021409862A Expired - Fee Related CN1216070C (zh) | 2001-07-13 | 2002-07-11 | 序列号20的生物活性肽 |
CNB021409870A Expired - Fee Related CN1210299C (zh) | 2001-07-13 | 2002-07-11 | 序列号19的生物活性肽 |
CNB021409714A Expired - Fee Related CN1210296C (zh) | 2001-07-13 | 2002-07-11 | 序列号30的生物活性肽 |
CNB021410372A Expired - Fee Related CN1210301C (zh) | 2001-07-13 | 2002-07-11 | 序列号18的生物活性肽 |
CNB021410410A Expired - Fee Related CN1213063C (zh) | 2001-07-13 | 2002-07-11 | 序列号12的生物活性肽 |
CN021409811A Expired - Fee Related CN1216072C (zh) | 2001-07-13 | 2002-07-11 | 序列号5的生物活性肽 |
CN02140982XA Expired - Fee Related CN1216073C (zh) | 2001-07-13 | 2002-07-11 | 序列号4的生物活性肽 |
CN021410437A Expired - Fee Related CN1216071C (zh) | 2001-07-13 | 2002-07-11 | 序列号27的生物活性肽 |
CNB021409846A Expired - Fee Related CN1210304C (zh) | 2001-07-13 | 2002-07-11 | 序列号3的生物活性肽 |
CNB021409838A Expired - Fee Related CN100412087C (zh) | 2001-07-13 | 2002-07-11 | 序列号2的生物活性肽 |
CN021409781A Expired - Fee Related CN1216069C (zh) | 2001-07-13 | 2002-07-11 | 序列号25的生物活性肽 |
CN021410399A Expired - Fee Related CN1216068C (zh) | 2001-07-13 | 2002-07-11 | 序列号14的生物活性肽 |
CNB021409854A Expired - Fee Related CN1210298C (zh) | 2001-07-13 | 2002-07-11 | 序列号1的生物活性肽 |
CNB02140979XA Expired - Fee Related CN1213060C (zh) | 2001-07-13 | 2002-07-11 | 序列号10的生物活性肽 |
CNB021409722A Expired - Fee Related CN1213065C (zh) | 2001-07-13 | 2002-07-11 | 序列号7的生物活性肽 |
CNB021409692A Expired - Fee Related CN1210293C (zh) | 2001-07-13 | 2002-07-11 | 序列号23的生物活性肽 |
CNB021409773A Expired - Fee Related CN1213067C (zh) | 2001-07-13 | 2002-07-11 | 序列号9的生物活性肽 |
CNB021410445A Expired - Fee Related CN1223603C (zh) | 2001-07-13 | 2002-07-11 | 序列号26的生物活性肽 |
CNB021410380A Expired - Fee Related CN1215081C (zh) | 2001-07-13 | 2002-07-11 | 序列号16的生物活性肽 |
CNB021410364A Expired - Fee Related CN1210300C (zh) | 2001-07-13 | 2002-07-11 | 序列号29的生物活性肽 |
CNB021409706A Expired - Fee Related CN1210294C (zh) | 2001-07-13 | 2002-07-11 | 序列号21的生物活性肽 |
CNB021410429A Expired - Fee Related CN1213064C (zh) | 2001-07-13 | 2002-07-11 | 序列号28的生物活性肽 |
CN021409757A Expired - Fee Related CN1216067C (zh) | 2001-07-13 | 2002-07-11 | 序列号15的生物活性肽 |
CNB021409749A Expired - Fee Related CN1210297C (zh) | 2001-07-13 | 2002-07-11 | 序列号17的生物活性肽 |
CNB021409684A Expired - Fee Related CN1210292C (zh) | 2001-07-13 | 2002-07-11 | 序列号22的生物活性肽 |
CNB021410356A Expired - Fee Related CN1223602C (zh) | 2001-07-13 | 2002-07-11 | 序列号11的生物活性肽 |
CNB021409803A Expired - Fee Related CN1213061C (zh) | 2001-07-13 | 2002-07-11 | 序列号6的生物活性肽 |
CNB021409730A Expired - Fee Related CN1210295C (zh) | 2001-07-13 | 2002-07-11 | 序列号24的生物活性肽 |
CNB021409765A Expired - Fee Related CN1213066C (zh) | 2001-07-13 | 2002-07-11 | 序列号8的生物活性肽 |
Country Status (2)
Country | Link |
---|---|
US (6) | US7491689B2 (zh) |
CN (30) | CN1213062C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI353252B (en) | 2004-04-28 | 2011-12-01 | Cms Peptides Patent Holding Company Ltd | Biologically active peptide vapeehptllteaplnpk der |
CN1799623B (zh) * | 2005-01-05 | 2011-01-26 | 康哲医药研究(深圳)有限公司 | 生物活性肽在制备用于防治关节炎的药物中的用途 |
RU2423375C2 (ru) | 2005-07-26 | 2011-07-10 | СиЭмЭс ПЕПТАЙДЗ ПЭЙТЕНТ ХОЛДИНГ КОМПАНИ ЛИМИТЕД | Новые биологически активные пептиды и их новое применение |
CN105254708B (zh) * | 2015-11-24 | 2019-03-12 | 福州大学 | 一种胡萝卜籽抗氧化三肽及其制备方法与应用 |
WO2019161487A1 (en) * | 2018-02-20 | 2019-08-29 | University Of Manitoba | Food protein-derived peptides as bitter taste blockers |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1142571A (en) | 1966-02-22 | 1969-02-12 | Walter Friedrich Wilhelm Kuhlm | A new polypeptide, and a method of preparing it |
US3992364A (en) | 1966-02-22 | 1976-11-16 | Walter Kuhlmey | Physiologically active polypeptide preparation |
EP0585957A1 (en) | 1986-08-06 | 1994-03-09 | Ajinomoto Co., Inc. | Recombinant B-cell differentiation factor |
US5449759A (en) * | 1987-05-16 | 1995-09-12 | Somatogen, Inc. | Hemoglobins with intersubunit desulfide bonds |
DE3827490A1 (de) | 1988-08-12 | 1990-02-15 | Hor Fer Vit Pharma Gmbh | Herrichtung und verwendung eines physiologisch aktiven polypeptids zur aids-therapie |
EP0382012B1 (en) | 1989-01-25 | 1995-05-17 | Commonwealth Scientific And Industrial Research Organisation | Polypeptides, antigens or vaccines protective against babesiosis |
US5242821A (en) | 1989-07-10 | 1993-09-07 | Valio, Finnish Co-Operative Dairies' Association | Lactococcus promoter and signal sequences for expression in bacteria |
US5173426A (en) * | 1989-10-06 | 1992-12-22 | Yale University | DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin |
AU7142391A (en) | 1989-12-22 | 1991-07-24 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Synthetic peptides as modulators of functional responses of intact cells |
WO1992009300A1 (en) * | 1990-11-21 | 1992-06-11 | Iterex Pharmaceuticals Ltd. Partnership | Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
DE4122585C2 (de) | 1991-07-08 | 1994-11-03 | Horfervit Pharma Gmbh | Verwendung einer Peptidfraktion bei Stoffwechselstörungen mit Gewichtsverlust |
US5780036A (en) | 1991-08-26 | 1998-07-14 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus |
US5556744A (en) * | 1992-05-29 | 1996-09-17 | The Trustees Of The University Of Pennsylvania | Methods and compositions for diagnosing and treating certain HIV infected patients |
ATE253635T1 (de) | 1993-06-15 | 2003-11-15 | Du Pont | Rekombinante spinnerseide analoge |
US5519114A (en) | 1993-10-29 | 1996-05-21 | University Of Florida Research Foundation, Inc. | Retroviral superantigens, superantigen peptides, and methods of use |
US6013628A (en) * | 1994-02-28 | 2000-01-11 | Regents Of The University Of Minnesota | Method for treating conditions of the eye using polypeptides |
US5760000A (en) * | 1994-05-13 | 1998-06-02 | University Technologies International,Inc. | Inhibition of liver cancer by the use of GnRH and GnRH analogs |
WO1995035389A1 (en) | 1994-06-17 | 1995-12-28 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for introduction of genetic material into microorganisms and transformants obtained therewith |
US5958416A (en) | 1994-12-16 | 1999-09-28 | Regents Of The University Of Minnesota | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
US5874405A (en) | 1994-12-16 | 1999-02-23 | Birnbaum; Gary | Heat shock protein peptides that share sequences with cyclic nucleotide phosphodiesterase and methods for modulating autoimmune central nervous system disease |
IL115199A (en) | 1995-09-07 | 2005-05-17 | Opperbas Holding Bv | Composition comprising a polynucleic acid molecule in a liposome and method using said composition |
GB9606016D0 (en) | 1996-03-22 | 1996-05-22 | Smithkline Beecham Plc | Novel use |
US5861483A (en) | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
SE9603468D0 (sv) | 1996-09-23 | 1996-09-23 | Astra Ab | New compounds |
DE19700535C1 (de) | 1997-01-10 | 1998-07-02 | Horfervit Pharma Gmbh | Verwendung eines physiologisch aktiven Polypeptids |
WO1998054339A1 (en) | 1997-05-27 | 1998-12-03 | Hanil Synthetic Fiber Co., Ltd. | PROCESS FOR PREPARING RECOMBINANT PROTEINS USING HIGHLY EFFICIENT EXPRESSION VECTOR FROM $i(SACCHAROMYCES CEREVISIAE) |
EP1012157A1 (en) | 1997-06-20 | 2000-06-28 | Human Genome Sciences, Inc. | $i(BORRELIA BURGDORFERI) POLYNUCLEOTIDES AND SEQUENCES |
IL121191A0 (en) | 1997-06-29 | 1997-11-20 | Yeda Res & Dev | Synthetic peptides and pharmaceutical compositions comprising them |
KR19990024297A (ko) | 1997-08-07 | 1999-04-06 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
US6036652A (en) * | 1998-05-12 | 2000-03-14 | Colin Corporation | Blood pressure estimating apparatus and method |
US6245427B1 (en) | 1998-07-06 | 2001-06-12 | DüZGüNES NEJAT | Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles |
WO2000012762A1 (en) | 1998-09-01 | 2000-03-09 | Millennium Pharmaceuticals, Inc. | A novel protein related to melanoma-inhibiting protein and uses thereof |
US6413530B1 (en) | 1999-04-21 | 2002-07-02 | University Of Florida Research Foundation, Inc. | Pesticidal peptides |
FR2794370B1 (fr) | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
AU7899100A (en) | 1999-10-18 | 2001-04-30 | Shanghai Bio Road Gene Development Ltd. | A novel polypeptide, a human casein kinase 48 and the polynucleotide encoding the polypeptide |
EP1478659B1 (en) | 2001-07-13 | 2008-11-12 | CMS Peptides Patent Holding Company Limited | Biologically active peptides |
US20040043438A1 (en) * | 2002-05-16 | 2004-03-04 | Alk-Abello A/S | Allergen mutants |
-
2002
- 2002-07-11 CN CNB021410402A patent/CN1213062C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN021409862A patent/CN1216070C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409870A patent/CN1210299C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409714A patent/CN1210296C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410372A patent/CN1210301C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410410A patent/CN1213063C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN021409811A patent/CN1216072C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN02140982XA patent/CN1216073C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN021410437A patent/CN1216071C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409846A patent/CN1210304C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409838A patent/CN100412087C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN021409781A patent/CN1216069C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN021410399A patent/CN1216068C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409854A patent/CN1210298C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB02140979XA patent/CN1213060C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409722A patent/CN1213065C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409692A patent/CN1210293C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409773A patent/CN1213067C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410445A patent/CN1223603C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410380A patent/CN1215081C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410364A patent/CN1210300C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409706A patent/CN1210294C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410429A patent/CN1213064C/zh not_active Expired - Fee Related
- 2002-07-11 CN CN021409757A patent/CN1216067C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409749A patent/CN1210297C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409684A patent/CN1210292C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021410356A patent/CN1223602C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409803A patent/CN1213061C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409730A patent/CN1210295C/zh not_active Expired - Fee Related
- 2002-07-11 CN CNB021409765A patent/CN1213066C/zh not_active Expired - Fee Related
- 2002-09-05 US US10/237,405 patent/US7491689B2/en not_active Expired - Lifetime
-
2006
- 2006-06-16 US US11/455,289 patent/US7402653B2/en not_active Expired - Fee Related
- 2006-07-18 US US11/458,113 patent/US7718768B2/en not_active Expired - Fee Related
- 2006-07-31 US US11/460,998 patent/US7696152B2/en not_active Expired - Fee Related
-
2007
- 2007-05-22 US US11/751,636 patent/US20070232522A1/en not_active Abandoned
-
2008
- 2008-03-17 US US12/049,382 patent/US20080293641A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1213062C (zh) | 序列号13的生物活性肽 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YITAI MEDICINE RESEARCH (SHENZHEN) CO., LTD. Free format text: FORMER OWNER: KANGZHE PHARMACEUTICAL INDUSTRY CO., LTD., SHENZHEN Effective date: 20030807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030807 Address after: 518029, Guangdong, Shenzhen Futian District Bagua three road deep medicine building, room 301-304 Applicant after: Yitai Medicine Research (Shenzhen) Co., Ltd. Address before: 518029, Guangdong, Shenzhen, Futian District Bagua three road deep medicine building on the eastern side of the two floor Applicant before: Kangzhe Pharmaceutical Industry Co., Ltd., Shenzhen |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: KANGZHE MEDICINE RESEARCH ( SHENZHEN ) CO., LTD. Free format text: FORMER NAME OR ADDRESS: YITAI MEDICINE RESEARCH (SHENZHEN) CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 518000. A biological incubator building in central high tech Zone, Guangdong, Shenzhen province 2-413 Patentee after: Pepharm R. & D. Ltd. Address before: 518029, Guangdong, Shenzhen Futian District Bagua three road deep medicine building, room 301-304 Patentee before: Yitai Medicine Research (Shenzhen) Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050803 Termination date: 20210711 |